Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 12276 - 12300 of 12824 in total
Fluorofuranylnorprogesterone F-18 is under investigation in clinical trial NCT02455453 (Assessment of Functional Status of Estrogen Receptors in Breast Cancer by Positron Emission Tomography).
Investigational
Matched Description: … Functional Status of Estrogen Receptors in Breast Cancer by Positron Emission Tomography). ... Fluorofuranylnorprogesterone F-18 is under investigation in clinical trial NCT02455453 (Assessment of …
IDE-196 is under investigation in clinical trial NCT03947385 (Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC Fusions).
Investigational
Matched Description: … IDE-196 is under investigation in clinical trial NCT03947385 (Study of IDE196 in Patients With Solid …
Luvadaxistat is under investigation in clinical trial NCT03214588 (Efficacy, Tolerability, and Pharmacokinetics of Multiple Doses of Oral TAK-831 in Adults With Friedreich Ataxia).
Investigational
Matched Description: … of Multiple Doses of Oral TAK-831 in Adults With Friedreich Ataxia). ... Luvadaxistat is under investigation in clinical trial NCT03214588 (Efficacy, Tolerability, and Pharmacokinetics …
Abiraterone decanoate is under investigation in clinical trial NCT04729114 (Open-label, Multicenter Study of Intramuscular PRL-02 Depot in Patients With Advanced Prostate Cancer).
Investigational
Matched Description: … of Intramuscular PRL-02 Depot in Patients With Advanced Prostate Cancer). ... Abiraterone decanoate is under investigation in clinical trial NCT04729114 (Open-label, Multicenter Study …
PCLX-001 is a first-in-kind N-Myristoyltransferase (NMT) inhibitor being developed by Pacylex Pharmaceuticals (https://pacylex.com). Current studies have shown that PCLX-001 works differently than other known cancer drugs and has high activity and positive results in breast, lung, bladder and pancreas cancers.
Investigational
Matched Description: … PCLX-001 is a first-in-kind N-Myristoyltransferase (NMT) inhibitor being developed by [Pacylex Pharmaceuticals ... PCLX-001 works differently than other known cancer drugs and has high activity and positive results in
Eptacog alfa pegol (activated) has been used in trials studying the prevention and treatment of Haemophilia A, Haemophilia B, Congenital Bleeding Disorder, Haemophilia B With Inhibitors, and Haemophilia A With Inhibitors.
Investigational
Matched Description: … Eptacog alfa pegol (activated) has been used in trials studying the prevention and treatment of Haemophilia …
Technetium-99m is the metastable isotope of technetium. It is commonly symbolized as 99mTc and used in the area of medical diagnosis. Technetium-99m is the most commonly used medical radioisotope.
Experimental
Matched Description: … It is commonly symbolized as 99mTc and used in the area of medical diagnosis. …
Biropepimut-S is under investigation in clinical trial NCT02873819 (Safety and Efficacy Study of GL-0817 (With Cyclophosphamide) for the Prevention of Recurrence of Squamous Cell Carcinoma of the Oral Cavity).
Investigational
Matched Description: … Biropepimut-S is under investigation in clinical trial NCT02873819 (Safety and Efficacy Study of GL-0817 …
Aspartyl-alanyl-diketopiperazine is under investigation in clinical trial NCT03349645 (An Open Label Extension Study to Assess the Safety of Long-Term Treatment With Ampion for Severe OA of the Knee).
Investigational
Matched Description: … Aspartyl-alanyl-diketopiperazine is under investigation in clinical trial NCT03349645 (An Open Label …
XL019 is a selective inhibitor of the cytoplasmic tyrosine kinase JAK2. An IND for XL019 was filed by Exelixis in May 2007.
Investigational
Matched Description: … An IND for XL019 was filed by Exelixis in May 2007. …
Danegaptide has been investigated for the treatment of Focus of Study is STEMI.
Investigational
Olendalizumab is under investigation in clinical trial NCT01883544 (Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ALXN1007 in Healthy Male and Female Subjects).
Investigational
Matched Description: … , Pharmacokinetics, and Pharmacodynamics of ALXN1007 in Healthy Male and Female Subjects). ... Olendalizumab is under investigation in clinical trial NCT01883544 (Study to Evaluate the Safety, Tolerability …
Uteroglobin is under investigation in clinical trial NCT01473264 (Safety, Pk and Anti-inflammatory Effects of CC10 Protein in Premature Infants With Respiratory Distress Syndrome (RDS)).
Investigational
Matched Description: … of CC10 Protein in Premature Infants With Respiratory Distress Syndrome (RDS)). ... Uteroglobin is under investigation in clinical trial NCT01473264 (Safety, Pk and Anti-inflammatory Effects …
Retagliptin is under investigation in clinical trial NCT02822534 (The Pharmacokinetics and Pharmacodynamics Study of Single and Multiple Dose of SP2086 in Type 2 Diabetes Patients).
Investigational
Matched Description: … Study of Single and Multiple Dose of SP2086 in Type 2 Diabetes Patients). ... Retagliptin is under investigation in clinical trial NCT02822534 (The Pharmacokinetics and Pharmacodynamics …
Pepinemab is under investigation in clinical trial NCT03769155 (VX15/2503 With or Without Ipilimumab and/or Nivolumab in Patients With Resectable Stage IIIB-D Melanoma).
Investigational
Matched Description: … and/or Nivolumab in Patients With Resectable Stage IIIB-D Melanoma). ... Pepinemab is under investigation in clinical trial NCT03769155 (VX15/2503 With or Without Ipilimumab …
Dalosirvat is under investigation in clinical trial NCT03742518 (A Study Evaluating the Efficacy and Safety of SM04554 Topical Solution in Male Subjects With Androgenetic Alopecia).
Investigational
Matched Description: … Safety of SM04554 Topical Solution in Male Subjects With Androgenetic Alopecia). ... Dalosirvat is under investigation in clinical trial NCT03742518 (A Study Evaluating the Efficacy and …
Tegileridine is under investigation in clinical trial NCT06458400 (To Evaluate the Efficacy and Safety of Tegileridine and Oliceridine Injections in the Treatment of Postoperative Pain).
Investigational
Matched Description: … of Tegileridine and Oliceridine Injections in the Treatment of Postoperative Pain). ... Tegileridine is under investigation in clinical trial NCT06458400 (To Evaluate the Efficacy and Safety …
Avenciguat is under investigation in clinical trial NCT05282121 (A Study to Test Whether BI 685509 Alone or in Combination With Empagliflozin Helps People With Liver Cirrhosis Caused by Viral Hepatitis or Non-alcoholic Steatohepatitis (NASH) Who Have High Blood Pressure in the Portal Vein (Main Vessel Going to the Liver)).
Investigational
Matched Description: … Avenciguat is under investigation in clinical trial NCT05282121 (A Study to Test Whether BI 685509 Alone ... or in Combination With Empagliflozin Helps People With Liver Cirrhosis Caused by Viral Hepatitis or ... Non-alcoholic Steatohepatitis (NASH) Who Have High Blood Pressure in the Portal Vein (Main Vessel Going …
CD276 (B7-H3) is a B7/CD28 immunoglobulin superfamily member frequently expressed among solid human tumours.[A242487, A242492] Omburtamab, formerly the murine anti-B7-H3 antibody 8H9, and its humanized forms are currently under clinical development for use in various cancers. Omburtamab is under investigation in clinical trial NCT03275402 (131i-omburtamab Radioimmunotherapy for Neuroblastoma Central Nervous...
Investigational
Matched Description: … murine anti-B7-H3 antibody 8H9, and its humanized forms are currently under clinical development for use in ... [A191829] Omburtamab is under investigation in clinical trial NCT03275402 (131i-omburtamab Radioimmunotherapy …
Semapimod has been used in trials studying the treatment of Crohn Disease.
Investigational
Matched Description: … Semapimod has been used in trials studying the treatment of Crohn Disease. …
Namitecan has been used in trials studying the treatment of Solid Tumors.
Investigational
Matched Description: … Namitecan has been used in trials studying the treatment of Solid Tumors. …
BLXA4 has been used in trials studying the treatment of Gingival Inflammation.
Investigational
Matched Description: … BLXA4 has been used in trials studying the treatment of Gingival Inflammation. …
Secoisolariciresinol has been used in trials studying the prevention of Breast Cancer.
Investigational
Matched Description: … Secoisolariciresinol has been used in trials studying the prevention of Breast Cancer. …
Talsaclidine has been used in trials studying the treatment of Alzheimer Disease.
Investigational
Matched Description: … Talsaclidine has been used in trials studying the treatment of Alzheimer Disease. …
Displaying drugs 12276 - 12300 of 12824 in total